S. Phanstiel

Président chez MYRIAD GENETICS, INC. Fortune : 7 M $ au 30/06/2026

Profil

S.
Louise Phanstiel currently serves as Chairman at Myriad Genetics, Inc. since 2020, and has been with the company since 2009.
Also holds director positions at Partnership for Public Service, Stony Brook Foundation, Inc., Southampton Hospital Association, and Butterfly Network, Inc. since 2021.
Serves as Trustee at Syracuse University.
Former roles include Director at Charles River Laboratories, Inc., Inveresk Research Group, Inc., and Cedars-Sinai Health System.
Served as Independent Director at Verastem, Inc. from 2012 to 2018.
Held the position of CFO, Chief Accounting Officer, SVP & Controller at Blue Cross of California in 2000.
Was Partner at Coopers & Lybrand LLP.
Served as President-Specialty Products at Elevance Health, Inc. from 2003 to 2007.
Education includes undergraduate studies at Golden Gate University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
BUTTERFLY NETWORK, INC. CLASS A 0,25%	22/06/2026	576 213 ( 0,25% )	5 M $	30/06/2026
MYRIAD GENETICS, INC. 0,4%	04/06/2026	374 771 ( 0,4% )	2 M $	30/06/2026

Postes actifs de S. Phanstiel

Sociétés	Poste	Début
MYRIAD GENETICS, INC.	Président	23/03/2020
BUTTERFLY NETWORK, INC.	Directeur/Membre du Conseil	12/02/2021
Stony Brook Foundation, Inc.	Directeur/Membre du Conseil	-
Southampton Hospital Association	Directeur/Membre du Conseil	-
Syracuse University	Directeur/Membre du Conseil	-
Partnership for Public Service	Directeur/Membre du Conseil	-

Anciens postes connus de S. Phanstiel

Sociétés	Poste	Fin
VERASTEM, INC.	Directeur/Membre du Conseil	16/10/2018
ELEVANCE HEALTH, INC.	Corporate Officer/Principal	01/01/2007
Blue Cross of California	Directeur Financier/CFO	01/01/2000
░░░░░░ ░░░░░ ░░░░░░ ░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░ ░░░░░ ░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-